Certara Inc Ordinary Shares CERT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
-
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
-
The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
-
The Quiet Bottleneck in AI Drug Discovery Isn't the Model — It's the Biology Underneath It
-
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
-
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm
Trading Information
- Previous Close Price
- $6.79
- Day Range
- $6.61–6.99
- 52-Week Range
- $4.45–13.88
- Bid/Ask
- $6.77 / $6.85
- Shares Outstanding
- 155.56M
- Market Cap
- $1.05B
- Volume/Avg
- 5M / 4M
Key Statistics
- Price/Earnings (Normalized)
- 16.79
- Price/Sales
- 2.49
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 4.05%
Company Profile
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,576
- Website
- https://www.certara.com
Valuation
|
Metric
|
CERT
|
|---|---|
Price/Earnings (Normalized) | 16.79 |
Price/Book Value | 0.99 |
Price/Sales | 2.49 |
Price/Cash Flow | 13.96 |
Price/Earnings
CERT
Financial Strength
|
Metric
|
CERT
|
|---|---|
Quick Ratio | 1.78 |
Current Ratio | 1.88 |
Interest Coverage | 0.75 |
Quick Ratio
CERT
Profitability
|
Metric
|
CERT
|
|---|---|
Return on Assets (Normalized) | 4.10% |
Return on Equity (Normalized) | 5.96% |
Return on Invested Capital (Normalized) | 5.79% |
Return on Assets
CERT
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|Rbxcxt^g | LOCK|m?# | $31B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|@^l@Y | $14B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|P!Gc< | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|&&p> | $14B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|^r | $10B | |||
| HealthEquity Inc
HQY
| — | LOCK|Ccp? | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|CW!&W | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|Mm | $7B | |||
| 10x Genomics Inc Ordinary Shares - Class A
TXG
| — | LOCK|#W | $5B | |||
| Waystar Holding Corp
WAY
| — | LOCK|@s | $4B |
United States